COVID-19 Detection Kits

COVID-19 Detection Kits Market Outlook

The global COVID-19 Detection Kits market is projected to reach approximately USD 15 billion by 2035, growing at a compound annual growth rate (CAGR) of around 5% during the forecast period from 2025 to 2035. This growth can be attributed to the increasing prevalence of COVID-19 cases globally, along with the rising demand for rapid and accurate testing solutions. Additionally, advancements in technology have led to the development of more efficient testing kits that provide faster results, which is crucial in managing outbreaks effectively. The emphasis on maintaining public health safety and the growing awareness regarding the importance of early detection are further fueling the demand for these kits. The ongoing investments in research and development, along with government initiatives to enhance testing capacities, play a significant role in propelling the market forward.

Growth Factor of the Market

The growth of the COVID-19 Detection Kits market is significantly influenced by several key factors, most notably the urgent need for effective testing solutions in the face of ongoing pandemic challenges. The rapid spread of COVID-19 variants necessitates frequent and efficient testing, leading to an increased demand for various types of detection kits. Furthermore, as governments worldwide implement measures to control outbreaks, the requirement for testing kits has surged, particularly in hospitals and health care facilities. The expansion of at-home testing options has also contributed to market growth, allowing individuals to test conveniently and safely. Additionally, rising investments from both public and private sectors in diagnostic research are paving the way for innovations in detection technology, ensuring that testing methods evolve to meet current health crises.

Key Highlights of the Market

• The global COVID-19 Detection Kits market is witnessing significant growth due to the ongoing pandemic.
• Rapid Antigen Test Kits are gaining popularity due to their speed and ease of use.
• Home Care Settings are increasingly becoming a major end-user segment as individuals prefer self-testing.
• Technological advancements in detection methods are enhancing the accuracy and efficiency of testing kits.
• Government initiatives and funding for testing capabilities are driving market expansion.

By Product Type

RT-PCR Kits:

RT-PCR (Reverse Transcription Polymerase Chain Reaction) kits are recognized as one of the most reliable methods for detecting COVID-19 infections. These kits work by detecting the viral RNA present in samples collected from the respiratory tract. The accuracy of RT-PCR makes it a preferred choice in clinical settings, especially for confirming active infections. The increased adoption of RT-PCR kits is supported by their ability to detect the virus even in low concentrations, which is crucial for effective outbreak management. Additionally, the technical advancements in RT-PCR technology have allowed for quicker processing times, further enhancing their attractiveness in the market. The continuous demand for RT-PCR testing in hospitals and laboratories will maintain its status as a leading product type in the COVID-19 detection kits segment.

Rapid Antigen Test Kits:

Rapid Antigen Test Kits are gaining traction due to their ability to deliver results in a short time frame, often within 15 to 30 minutes. These kits work by identifying specific proteins found on the surface of the virus, making them a convenient option for on-site testing. The ease of use and fast results make rapid antigen tests ideal for situations where immediate testing is needed, such as at airports, schools, and workplaces. Although they may not offer the same level of accuracy as RT-PCR tests, the convenience of rapid antigen tests has led to their widespread adoption. The growing preference for quick and accessible testing options is expected to sustain the demand for rapid antigen test kits in the market.

Antibody Test Kits:

Antibody Test Kits are designed to detect the presence of antibodies in individuals who have previously been infected with the COVID-19 virus. These tests are particularly useful for understanding the immune response in populations and for epidemiological studies. While they do not confirm active infections, they provide valuable insights into the spread of the virus within communities. The demand for antibody test kits has seen a significant rise as public health agencies seek to track infection rates and immunity levels among populations. As vaccination campaigns continue, antibody testing will play a critical role in assessing the effectiveness of vaccines, thus maintaining its relevance in the market.

CRISPR-Based Test Kits:

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)-based test kits represent a cutting-edge approach to COVID-19 detection. Leveraging CRISPR technology, these kits offer high specificity and sensitivity in identifying viral RNA. The potential for rapid and cost-effective testing makes CRISPR an attractive technology in the diagnostics landscape. These kits are designed to be user-friendly and can be adapted for various testing settings, including home use. With ongoing research to optimize CRISPR-based tests, their market presence is likely to grow as healthcare systems seek efficient solutions for managing COVID-19 detection.

LAMP Kits:

LAMP (Loop-Mediated Isothermal Amplification) kits are another innovative method for detecting COVID-19 infections. Unlike traditional PCR methods, LAMP technology allows for rapid amplification of target DNA or RNA at a constant temperature, eliminating the need for complex thermal cycling equipment. This characteristic makes LAMP kits ideal for use in resource-limited settings or field testing scenarios. The speed of LAMP tests, often providing results in under an hour, contributes to their attractiveness in emergency situations. As the healthcare landscape adapts to the ongoing demands of the pandemic, LAMP kits are positioned as a valuable tool for effective COVID-19 testing.

By Application

Hospitals:

Hospitals are primary users of COVID-19 detection kits due to their critical role in managing infected patients. The need for accurate and timely testing is paramount in hospital settings, where early diagnosis can significantly affect treatment outcomes. Hospitals utilize a variety of detection kits, including RT-PCR and rapid antigen tests, to ensure comprehensive testing capabilities for patients presenting with respiratory symptoms. The demand for these kits in hospitals has surged as healthcare providers strive to contain the virus's spread within their facilities. The integration of advanced testing technologies within hospitals is expected to remain a key driver of market growth in the coming years.

Laboratories:

Laboratories serve as essential testing hubs for COVID-19 detection, employing a range of testing kits to support their diagnostic efforts. These facilities are equipped to handle complex testing procedures, making RT-PCR kits particularly prevalent in laboratory settings. The demand for lab-based testing is bolstered by the need for accuracy and reliability in detecting COVID-19 infections. Laboratories also play a crucial role in monitoring and researching the virus, using detection kits to conduct epidemiological studies and track variants. As the healthcare landscape continues to evolve, laboratories will remain integral to the COVID-19 detection framework.

Home Care Settings:

The rise of home care settings for COVID-19 testing reflects a shift towards more accessible and convenient testing options. Home testing kits allow individuals to collect samples and receive results without visiting healthcare facilities, promoting greater testing participation. The appeal of home care testing lies in its convenience and the ability to maintain social distancing, crucial during the pandemic. As public acceptance of at-home testing grows, manufacturers are focusing on developing user-friendly kits that provide accurate results. This segment is expected to see substantial growth as consumers prioritize safety and convenience in health management.

Research Institutes:

Research institutes are pivotal in the advancement of COVID-19 detection technologies, utilizing various detection kits for clinical research and studies. These institutions often collaborate with healthcare providers to evaluate the effectiveness of different testing methods and to understand the virus's behavior. The demand for detection kits within research settings is driven by the need for continuous learning and innovation in combating the pandemic. As research efforts intensify to develop vaccines and treatments, the utilization of COVID-19 detection kits in research institutes will remain significant, facilitating advancements in public health strategies.

By Distribution Channel

Hospitals Pharmacies:

Hospital pharmacies play a crucial role in the distribution of COVID-19 detection kits, ensuring that these essential tools are readily available for patient testing. The close proximity to clinical settings allows hospitals to maintain a steady supply of testing kits, particularly for RT-PCR and rapid antigen tests. The convenience of obtaining detection kits directly from hospital pharmacies enhances the efficiency of testing procedures within healthcare facilities. Additionally, as hospitals continue to prioritize patient safety and swift diagnosis, the demand for testing kits through hospital pharmacies is expected to remain strong. This segment is vital for maintaining an effective testing strategy as hospitals navigate ongoing pandemic challenges.

Online Sales:

Online sales channels have revolutionized the distribution landscape for COVID-19 detection kits, providing consumers with easy access to testing solutions from the comfort of their homes. E-commerce platforms facilitate the purchase of at-home testing kits, catering to the rising demand for convenience and safety in health management. The online sales channel has gained traction due to its ability to reach a broader audience, especially during periods of heightened concern regarding in-person visits to healthcare facilities. As consumers increasingly turn to online shopping for health-related products, the online sales segment is poised for continued growth in the COVID-19 detection kits market.

Diagnostic Centers:

Diagnostic centers serve as dedicated facilities for various medical testing services, including COVID-19 detection. These centers are equipped to handle a high volume of tests, utilizing sophisticated detection kits to provide accurate and timely results. The demand for testing kits in diagnostic centers is driven by the need for comprehensive testing solutions, particularly in regions where healthcare access may be limited. The convenience of having a specialized facility for testing enhances patient participation and supports public health initiatives. As the pandemic evolves, diagnostic centers will remain key players in the COVID-19 detection landscape, ensuring communities remain vigilant and informed.

Retail Pharmacies:

Retail pharmacies are increasingly becoming an important distribution channel for COVID-19 detection kits, catering to the growing demand for accessible testing solutions. Many pharmacies have begun offering at-home testing kits, along with professional testing services, allowing customers to choose their preferred method of testing. The convenience of retail pharmacies—often located in community settings—makes them a vital resource for individuals seeking COVID-19 testing. The collaboration between pharmacies and healthcare providers to promote testing awareness further enhances the role of retail pharmacies in the market. As public interest in self-testing continues to rise, retail pharmacies will play a significant role in facilitating access to COVID-19 detection kits.

By End User

Hospitals:

Hospitals serve as primary end-users of COVID-19 detection kits, relying heavily on these tools for diagnosing and managing patient care. The urgency of accurately identifying COVID-19 cases within hospital settings is paramount, as it directly impacts infection control measures and patient outcomes. Hospitals utilize a wide variety of detection kits, including RT-PCR and rapid antigen tests, to ensure comprehensive testing capabilities are in place. The demand for these kits remains high, driven by the need to maintain operational efficiency and provide timely treatment for patients. As the landscape of the pandemic continues to evolve, hospitals will continue to be a central focus for COVID-19 detection efforts.

Diagnostic Centers:

Diagnostic centers are specialized facilities dedicated to various types of medical testing, and they play a crucial role in the COVID-19 detection landscape. These centers utilize a range of detection kits to meet the demands of their communities, often providing rapid testing services to facilitate quick results. The ability to accommodate high volumes of tests enables diagnostic centers to effectively contribute to public health efforts in monitoring and controlling the spread of the virus. The ongoing need for accurate testing solutions ensures that diagnostic centers will remain significant end-users of COVID-19 detection kits as the market continues to evolve.

Research Institutes:

Research institutes are pivotal in driving innovation and understanding the implications of COVID-19 through the utilization of detection kits. These institutions engage in extensive research and collaboration with healthcare organizations, utilizing various testing kits to gather data and insights related to the virus. The demand for COVID-19 detection kits within research settings is fueled by the ongoing need to understand the virus’s behavior and develop effective treatment options. As research efforts intensify, particularly in the context of emerging variants and vaccine efficacy, the role of research institutes as end-users of detection kits will continue to be significant, contributing to the overall advancement of public health knowledge and strategies.

Home Care Settings:

Home care settings have gained prominence as end-users of COVID-19 detection kits, reflecting a shift towards self-testing and convenience in health management. The emergence of at-home testing kits allows individuals to conduct tests without needing to visit healthcare facilities, promoting greater accessibility to testing services. As consumers prioritize safety and ease of use, home care settings are increasingly adopting testing kits to monitor their health and manage potential infections. The growth of this segment is driven by the desire for independence in health management and the need to maintain social distancing practices during the pandemic. As the adoption of at-home testing continues to rise, it will play a vital role in shaping the future of the COVID-19 detection kits market.

By Region

The North American region is projected to hold a significant share of the COVID-19 Detection Kits market, estimated at around USD 5 billion by 2035, driven by a robust healthcare infrastructure and a high prevalence of testing. The United States, in particular, has witnessed a substantial demand for testing kits due to ongoing public health efforts to control the virus's spread. The rapid adoption of innovative testing technologies, including RT-PCR and rapid antigen tests, has contributed to the North American market's growth and development. Additionally, the region's commitment to research and development in diagnostics is expected to enhance the availability and accessibility of COVID-19 detection kits.

In Europe, the COVID-19 Detection Kits market is also experiencing significant growth, projected to reach approximately USD 4 billion by 2035, with a CAGR of around 6% during the forecast period. The European region has seen increased collaboration among governments, healthcare providers, and research institutions to enhance testing capacities. Countries such as Germany, France, and the UK are at the forefront of implementing widespread testing strategies, leading to a higher demand for various detection kits. Furthermore, the emphasis on improving healthcare systems and preparedness for future pandemics will likely drive the continued growth of the COVID-19 testing market in Europe.

Opportunities

The COVID-19 detection kits market presents numerous opportunities for growth, particularly in the development of innovative testing technologies. As research continues, advancements in diagnostic methods such as CRISPR and LAMP are expected to create niche markets for rapid and highly accurate testing solutions. The increasing focus on at-home testing also opens avenues for kit manufacturers to explore new product designs aimed at consumer usability and comfort. Additionally, expanding healthcare access in emerging markets provides further opportunities for the introduction of affordable and effective COVID-19 detection kits. As global health authorities prioritize preparedness against future pandemics, there is significant potential for investments in research and development that address both current and future testing needs.

Another notable opportunity lies in the collaboration between public and private sectors to enhance testing capabilities. Governments and healthcare organizations are increasingly recognizing the importance of widespread testing as a key strategy in combating COVID-19. This recognition opens doors for partnerships with diagnostic companies and research institutions to develop comprehensive testing solutions. Furthermore, educational initiatives aimed at increasing public awareness about the importance of regular testing can catalyze higher adoption rates and demand for COVID-19 detection kits. By leveraging these opportunities, stakeholders within the market can position themselves favorably in a rapidly evolving ecosystem.

Threats

Despite the promising growth of the COVID-19 detection kits market, several threats could impact its trajectory. One of the primary concerns is the emergence of counterfeit and substandard testing kits flooding the market, which can undermine public trust in testing solutions. As the demand for COVID-19 tests skyrockets, the potential for unethical manufacturers to exploit the situation increases, putting patients at risk. Regulatory bodies must remain vigilant in monitoring product quality and ensuring that only approved and validated testing kits are available to consumers. Additionally, the rapid pace of technological advancements could render existing testing kits obsolete, necessitating continuous innovation and adaptation from manufacturers to stay competitive.

Another significant threat is the potential for shifting public health policies and changing demand dynamics based on vaccination rates and the evolving nature of the virus. As more people become vaccinated and the prevalence of COVID-19 infections potentially decreases, the urgency for testing kits may diminish. This shift in focus could lead to a saturated market, where manufacturers may struggle to maintain sales and profitability. Companies must therefore adopt flexible business strategies that allow them to pivot and address new market needs as the pandemic situation evolves.

Competitor Outlook

• Abbott Laboratories
• Roche Diagnostics
• Thermo Fisher Scientific
• BD (Becton, Dickinson and Company)
• Siemens Healthineers
• Quidel Corporation
• Cepheid
• Hologic, Inc.
• Bio-Rad Laboratories
• PerkinElmer, Inc.
• GenMark Diagnostics
• F. Hoffmann-La Roche Ltd.
• Chembio Diagnostics
• Lexogen GmbH
• Novavax, Inc.

The overall competitive landscape of the COVID-19 detection kits market is characterized by the presence of several key players who are actively engaged in research, development, and innovation. Companies are focusing on diversifying their product portfolios to include a wide range of testing kits, such as RT-PCR, rapid antigen tests, and at-home testing solutions. Strategic collaborations and partnerships are also common among leading manufacturers as they seek to enhance their market presence and accelerate the development of testing technologies. The landscape remains dynamic, driven by the need for rapid and accurate testing solutions that can adapt to changing public health demands.

Abbott Laboratories stands out as a key player in the COVID-19 detection kits market, known for its innovative and reliable testing solutions. The company has developed a range of RT-PCR and rapid testing kits, which have been widely adopted in hospitals and laboratories. Abbott's commitment to quality and efficiency has positioned it as a trusted manufacturer in the diagnostics sector. Additionally, the company's extensive global distribution network allows for swift deployment of testing kits to regions most in need, further solidifying its competitive edge in the marketplace.

Roche Diagnostics is another prominent player in the COVID-19 detection kits market, offering a comprehensive portfolio of diagnostic solutions. The company has made significant investments in research and development to enhance its testing capabilities, particularly in RT-PCR technology. Roche's focus on innovative testing methods, combined with its strong reputation in the diagnostics industry, has enabled it to maintain a leading position in the market. Furthermore, Roche's collaborations with healthcare providers and research institutions bolster its capacity to deliver timely and accurate COVID-19 testing solutions.

Thermo Fisher Scientific is also a formidable competitor in the market, recognized for its advanced testing technologies and commitment to quality. The company's diverse range of COVID-19 detection kits caters to various testing environments, including hospitals, laboratories, and home care settings. Thermo Fisher's emphasis on innovation and customer support has enhanced its reputation as a leading supplier of diagnostic solutions. With ongoing efforts to expand its product offerings and meet the evolving demands of the healthcare sector, Thermo Fisher is well-positioned to thrive in the competitive landscape of COVID-19 detection kits.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Cepheid
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Lexogen GmbH
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Hologic, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Novavax, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 PerkinElmer, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Roche Diagnostics
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Quidel Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Abbott Laboratories
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Chembio Diagnostics
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 GenMark Diagnostics
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Bio-Rad Laboratories
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Siemens Healthineers
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Thermo Fisher Scientific
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 F. Hoffmann-La Roche Ltd.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 BD (Becton, Dickinson and Company)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 COVID-19 Detection Kits Market, By End User
    • 6.1.1 Hospitals
    • 6.1.2 Diagnostic Centers
    • 6.1.3 Research Institutes
    • 6.1.4 Home Care Settings
  • 6.2 COVID-19 Detection Kits Market, By Application
    • 6.2.1 Hospitals
    • 6.2.2 Laboratories
    • 6.2.3 Home Care Settings
    • 6.2.4 Research Institutes
  • 6.3 COVID-19 Detection Kits Market, By Product Type
    • 6.3.1 RT-PCR Kits
    • 6.3.2 Rapid Antigen Test Kits
    • 6.3.3 Antibody Test Kits
    • 6.3.4 CRISPR-Based Test Kits
    • 6.3.5 LAMP Kits
  • 6.4 COVID-19 Detection Kits Market, By Distribution Channel
    • 6.4.1 Hospitals Pharmacies
    • 6.4.2 Online Sales
    • 6.4.3 Diagnostic Centers
    • 6.4.4 Retail Pharmacies

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 COVID-19 Detection Kits Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global COVID-19 Detection Kits market is categorized based on

By Product Type

• RT-PCR Kits
• Rapid Antigen Test Kits
• Antibody Test Kits
• CRISPR-Based Test Kits
• LAMP Kits

By Application

• Hospitals
• Laboratories
• Home Care Settings
• Research Institutes

By Distribution Channel

• Hospitals Pharmacies
• Online Sales
• Diagnostic Centers
• Retail Pharmacies

By End User

• Hospitals
• Diagnostic Centers
• Research Institutes
• Home Care Settings

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Abbott Laboratories
• Roche Diagnostics
• Thermo Fisher Scientific
• BD (Becton, Dickinson and Company)
• Siemens Healthineers
• Quidel Corporation
• Cepheid
• Hologic, Inc.
• Bio-Rad Laboratories
• PerkinElmer, Inc.
• GenMark Diagnostics
• F. Hoffmann-La Roche Ltd.
• Chembio Diagnostics
• Lexogen GmbH
• Novavax, Inc.